Filing Details
- Accession Number:
- 0001127602-17-018729
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-19 08:17:52
- Reporting Period:
- 2017-05-17
- Filing Date:
- 2017-05-19
- Accepted Time:
- 2017-05-19 08:17:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
859737 | Hologic Inc | HOLX | X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) | 042902449 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1346770 | M Lawrence Levy | 250 Campus Drive Marlborough MA 01752 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-17 | 9,076 | $32.82 | 43,165 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-17 | 9,076 | $42.80 | 34,089 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-05-18 | 2,924 | $32.82 | 37,013 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-05-17 | 9,076 | $0.00 | 9,076 | $32.82 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-05-18 | 2,924 | $0.00 | 2,924 | $32.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,924 | 2008-01-01 | 2017-10-22 | No | 4 | M | Direct |
28,000 | 2008-01-01 | 2017-10-22 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing Rule 10b5-1 trading plan.
- The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $42.66 to $42.98 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Includes 2,427 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan.